SCHEMBL5000673

SCHEMBL5000673

CS(=O)(=O)c1ccc2c(c1)[nH]c(=O)n2C1CC2CCC(C1)N2CC(=O)N1CC2CCCC2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 4/20 0.46
CALCRL Q16602 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
CCR5 P51681 1/20 0.35
OPRK1 P41145 3/20 0.35
OPRL1 P41146 3/20 0.35
OPRD1 P41143 2/20 0.35
DRD2 P14416 4/20 0.35
CHRM1 P11229 3/20 0.35
PLD1 Q13393 4/20 0.34
HTR1A P08908 1/20 0.34
ADRA2A P08913 1/20 0.34
HTR2A P28223 1/20 0.34
SLC6A4 P31645 1/20 0.34
DRD3 P35462 1/20 0.34
CCR3 P51677 1/20 0.34
YEATS4 O95619 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5000679 0.85 OPRM1 (0.43) OPRM1CALCRLSIRT2USP2ALDH1A1
SCHEMBL4446003 0.85 OPRM1 (0.47) OPRM1CALCRLSIRT2CCR5OPRK1
SCHEMBL4444762 0.85 OPRM1 (0.57) OPRM1CALCRLSIRT2ALDH1A1OPRK1
SCHEMBL5000705 0.82 OPRM1 (0.45) OPRM1CALCRLSIRT2CCR5OPRK1
SCHEMBL5006610 0.77 PLD1 (0.35) USP2ALDH1A1LMNACHRM1PLD1
SCHEMBL4991406 0.73 OPRM1 (0.58) OPRM1CALCRLALDH1A1DRD2PLD1
SCHEMBL4435813 0.72 OPRM1 (0.57) OPRM1CALCRLALDH1A1DRD2CHRM1
SCHEMBL7191407 0.72 OPRM1 (0.54) OPRM1CALCRLSIRT2USP2ALDH1A1
SCHEMBL7191411 0.72 OPRM1 (0.54) OPRM1CALCRLSIRT2USP2ALDH1A1
SCHEMBL4438975 0.72 YEATS4 (0.49) USP2ALDH1A1LMNADRD2PLD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER INC 2008-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE SPTLC1, SPTLC2, CPT1A OPRM1 4069/4885CALCRL 1266/4885SIRT2 707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.